Michael W. Major studied Pharmacy at the Medical Academy in Lodz, Poland. Finished his academic carrier as a tenured Professor of Medicinal Chemist at age of 33. During his time at academia he published 40+ peer review publications and was an exchange scientist at Northwestern and McMaster University and Alexander von Humboldt scholar at University of Stuttgart.
Michael passed the Canadian Pharmacy Examining Board exam.
His career in Milwaukee, WI started with Aldrich Chemical, followed by Cambridge Chemical.
In 1998 he started Major Laboratories and in 1999 Cambridge Major Laboratories.
In 2003, built his first 60 000 Sq. Ft. R&D and small scale API manufacturing facility, follow by a second large scale API manufacturing site in 2008. Both facilities were operational one year from the start of construction. The company was sold in December 2012 for $212MM.
Founder and co-founder of few virtual companies focused on bringing to the market branded drugs and niche injectable generics. One of them, Namigen LLC formed in partnership with Nathan Barishansky, filed four ANDA submission. In December 2016 their first product, Sodium Nitroprusside Injection, got FDA approval.
After returning from France Michael finished construction of MPP and started to produce and develop nutraceuticals, medical devices and injectables. MPP is also set to offer services in stick-pack and bottle packaging and developing injectable drug products. The company has currently 14 employees.
Michael believes in science based manufacturing and organic growth.
In his words there are three components to success: hard work, knowledge and luck in approximate ratios of 50:49:1%. Michael believes no one can succeed in the long term if he is deprived of integrity, honesty, education, common sense, drive and leadership skills.
Michael enjoys the company of others, wine, travel, history and fine arts. He speaks five languages: Polish, German, English, Italian and French (still needs improvement).